Posts Tagged ‘ drug evaluation ’

FDA Requests Boxed Warnings on Fluoroquinolone Antimicrobial Drugs

Jul 8th, 2008 | By admin | Category: Safety News

The U.S. Food and Drug Administration (FDA) has notified manufacturers of fluoroquinolone antimicrobial drugs that a Boxed Warning in the product labeling concerning the increased risk of tendinitis and tendon rupture is necessary.
If you’re new here, you may want to subscribe to our RSS feed. Thanks for visiting!



FDA Obtains Permanent Injunction Against Scientific Laboratories, Inc.

May 16th, 2008 | By admin | Category: Safety News

The U.S. Food and Drug Administration (FDA) today announced that Scientific Laboratories Inc., and its president, Rajeshwari Patel, and chief executive officer, Amit Roy, have signed a Consent Decree of Permanent Injunction and are barred from manufacturing and distributing drug products until they bring their manufacturing operations [...]



FDA Approves Cimzia to Treat Crohn’s Disease

Apr 22nd, 2008 | By admin | Category: Health News

A new drug has been approved to help sufferers of Crohn’s disease, the U.S. Food and Drug Administration announced today. Cimzia (certolizumab pegol) received approval for adults with moderate to severe Crohn’s disease who have not responded to conventional therapies. This product was approved with a Medication Guide.



FDA Warns Consumers Not to Use “Blue Steel” And “Hero” Products

Mar 25th, 2008 | By admin | Category: Health News

The U.S. Food and Drug Administration is advising consumers not to purchase or use “Blue Steel” or “Hero” products marketed as dietary supplements throughout the United States because they are considered unapproved drugs and have not been proven to be safe or effective. These products contain undeclared ingredients, which may dangerously affect a person’s blood [...]